IRIS
ARNALDI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.401
EU - Europa 2.445
AS - Asia 860
AF - Africa 50
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 8.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.396
UA - Ucraina 511
IT - Italia 429
IE - Irlanda 417
SG - Singapore 360
SE - Svezia 320
CN - Cina 282
DE - Germania 244
DK - Danimarca 143
GB - Regno Unito 143
TR - Turchia 104
FI - Finlandia 97
FR - Francia 76
KR - Corea 71
CI - Costa d'Avorio 40
BE - Belgio 30
IN - India 21
IR - Iran 9
MA - Marocco 9
RU - Federazione Russa 9
CZ - Repubblica Ceca 6
NL - Olanda 6
AT - Austria 4
AU - Australia 4
CA - Canada 4
EU - Europa 4
LT - Lituania 4
VN - Vietnam 3
HK - Hong Kong 2
JO - Giordania 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BR - Brasile 1
BZ - Belize 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
NO - Norvegia 1
RO - Romania 1
Totale 8.767
Salva come PNG Salva come JPEG
Città #
Chandler 677
Jacksonville 672
Des Moines 455
Fairfield 425
Dublin 417
Boardman 359
Ashburn 320
Wilmington 219
Woodbridge 191
New York 182
Seattle 174
Ann Arbor 162
Lawrence 161
Princeton 161
Singapore 161
San Mateo 151
Houston 136
Cambridge 128
Centro 93
San Diego 55
Abidjan 40
Turin 38
Helsinki 31
Brussels 28
London 28
Shanghai 28
Los Angeles 27
Washington 24
Beijing 23
Guangzhou 23
Norwalk 21
Dallas 20
Pune 19
Civitanova Marche 16
Rome 16
Wuhan 14
New Bedfont 13
Ancona 11
Wuxi 11
Falls Church 10
Kilburn 10
Ascoli Piceno 9
Jinhua 9
Pescara 9
Redmond 9
Yiwu 9
Chiswick 7
Karaj 7
Milan 6
Olomouc 6
Camerino 5
Heze 5
Marche 5
Santa Clara 5
Senigallia 5
Shenzhen 5
Vallefoglia 5
Altenmarkt im Pongau 4
Auburn Hills 4
Istia D'ombrone 4
Ivrea 4
Jiaxing 4
Macerata 4
Naples 4
Ravenna 4
Seoul 4
Avellino 3
Brugherio 3
Como 3
Filottrano 3
Grumo Nevano 3
Hanover 3
Hounslow 3
Islington 3
Massarosa 3
Modugno 3
Monsampolo del Tronto 3
Padova 3
Porto 3
Porto San Giorgio 3
Prescot 3
San Jose 3
Amman 2
Benevento 2
Bologna 2
Boydton 2
Castelfidardo 2
Chongqing 2
Clifton 2
Dalian 2
Dong Ket 2
Florence 2
Hong Kong 2
Marano di Napoli 2
Montecatini Terme 2
Montréal 2
Moscow 2
New Delhi 2
Nowshahr 2
Parma 2
Totale 5.976
Salva come PNG Salva come JPEG
Nome #
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 126
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 120
Age-related modifications of the human growth hormone circadian secretory pattern studied with a new statistical method in healthy adults 107
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 106
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 106
Adrenal incidentaloma: surgical update. 98
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia. 97
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease. 96
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 96
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 95
Ruolo dell’osmolarità seminale nella regolazione della motilità degli spermatozoi nell’uomo 90
Diagnosis and complications of Cushing's syndrome: a consensus statement 89
Importance of sleep and melatonin for the human prolactin circadian secretory pattern in normal and pathological conditions 88
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. 88
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 87
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 87
Qualità della vita nei pazienti con sindrome adrenogenitale ed impatto della terapia sostitutiva. 87
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 83
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 82
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 82
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 82
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. 79
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 77
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 77
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. 77
Self image and quality of life in acromegaly 76
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 76
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 76
Echo Doppler in the characterization of thyroid nodular disease 75
How to improve effectiveness of pegvisomant treatment in acromegalic patients 75
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 73
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 73
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 71
Determinazione comparativa dei livelli del coenzima Q10 nelle oligozoospermie idiopatiche e nel varicocele 69
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 69
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 69
Glucocorticoid excess and COVID-19 disease 69
Pituitary adenoma apoplexy: Review of personal series. 68
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 67
New treatment guidelines on Cushing's disease. 66
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 66
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 65
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 65
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 65
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 65
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 64
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome. 64
An evaluation of the ultrastructural features improvement in idiopathic oligo-astenospermia after FSH treatment 64
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 64
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 64
Androgens in Cushing's Syndrome 64
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 63
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. 63
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 63
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 62
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 62
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 62
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 62
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 62
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 61
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study 61
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 61
Semen osmolarity and sperm motility 61
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 61
Harmful effects of functional hypercortisolism: a working hypothesis. 60
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 60
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 59
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 59
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 58
Analysis of GRP101 and AIP genes mutations in acromegaly: a multicentre study 58
Acromegaly and male sexual health 57
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 57
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 57
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. 55
Cardiovascular risk in Cushing's syndrome. 53
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 53
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. 53
Coagulopathy in Cushing's syndrome. 52
Adrenal incidentaloma. 52
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. 52
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. 51
Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease. 50
Protective role of ubiquinol-10 against peroxidation in human seminal fluid plasma 50
Advances in medical treatment of Cushing’s disease 49
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. 49
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 49
Decreased resistance to toxicity of reactive oxygen species in seminal plasma of asthenospermic individuals 49
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart. 48
COVID-19 and endocrine and metabolic disorders: critical points and suggestions for a correct therapeutic management from a tertiary endocrine center in Italy 48
Pituitary-directed medical treatment of Cushing’s disease. 47
Histological contamination in clinical research: from ultrastrcture to stem cel biology. 47
Potential indications for somatostatin analogs in Cushing's syndrome. 46
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 46
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations 46
Effects of exogenous CoQ10 administration in patients with idiopathic asthenozoospermia 46
Approach to the patient with possible Cushing's syndrome 45
Impatto della terapia sostitutiva sulla qualità della vita nei pazienti con iperplasia surrenalica congenita. 45
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 44
The degree of urinary hypercortisolism is not correlated with the severity of Cushing's syndrome. 44
CoQ10 dietary implementation in patients with idiopathic asthenozoospermia 42
Totale 6.724
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020469 0 0 0 0 0 0 91 7 96 4 85 186
2020/20211.942 86 200 249 30 208 93 227 183 218 148 200 100
2021/20221.137 60 225 29 68 7 77 41 90 80 101 101 258
2022/20232.311 210 232 165 174 108 609 6 103 525 11 120 48
2023/20241.358 236 45 120 178 214 272 38 31 7 41 21 155
2024/2025783 324 226 81 28 66 56 2 0 0 0 0 0
Totale 8.991